aTyr Pharma Inc expected to post a loss of 24 cents a share - Earnings Preview

aTyr Pharma

07/08/2024 15:18

* aTyr Pharma Inc  ATYR.OQ   ATYR.O  is expected to show a
rise in
quarterly revenue when it reports  results on August 9
(estimated) for the period ending June 30 2024
    * The San Diego California-based  company is expected to
report
revenue of $24 thousand, according to the mean estimate from 5
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for aTyr Pharma Inc is for a
loss
of 24 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for aTyr Pharma
Inc
is $26.00​, above​ its last closing price of $1.87. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.25       -0.24      -0.23     Beat    2.5
 Dec. 31 2024              -0.24      -0.25     Missed  -5
 Sep. 30 2023  -0.22       -0.23      -0.20     Beat    11.5​
 Jun. 30 2023  -0.28       -0.28      -0.22     Beat    21
 ​​Mar.        -0.40       -0.40      -0.29     Beat    27.2
 31 2023                                                
 Dec. 31 2022  -0.48       -0.48      -0.26     Beat    45.8​
 Sep. 30 2022  -0.45       -0.46      -0.46     Met     0.4
 Jun. 30 2022  -0.39       -0.38      -0.44     Missed  -15.2
 This summary was machine generated August 7 at 14:18 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)